B. Coulm, C. Bonnet, B. Blondel, A. Vanhaesebrouck, A. Vilain et al., Enquête nationale périnatale. Rapport 2016. Les naissances et les établissements, situation et évolution depuis 2010

D. Inserm, http://ljournal.ru/wp-content/uploads/2017/03/a-2017-023.pdf, p.317, 2017.

, Withdrawal from the labour market at childbirth can have long?lasting effects on women's careers, Labour and Social Affairs, vol.2, 2018.

C. Lévy-marchal, A. Fagot-campagna, and M. Daniel, Surveillance épidémiologique du diabète de l'enfant

D. Dabelea, E. J. Mayer-davis, S. Saydah, G. Imperatore, B. Linder et al., Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009, JAMA, vol.311, issue.17, p.1778, 2014.

R. Bell, K. Bailey, T. Cresswell, G. Hawthorne, J. Critchley et al., Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes, BJOG: An International Journal of Obstetrics and Gynaecology, vol.115, issue.4, pp.445-452, 2008.

S. T. Mackin, S. M. Nelson, J. J. Kerssens, R. Wood, S. Wild et al., Diabetes and pregnancy: national trends over a 15 year period, Diabetologia, vol.61, issue.5, pp.1081-1089, 2018.

D. S. Feig, J. Hwee, B. R. Shah, G. L. Booth, A. S. Bierman et al., Trends in Incidence of Diabetes in Pregnancy and Serious Perinatal Outcomes: A Large, Population-Based Study in Ontario, Canada, 1996?2010, Diabetes Care, vol.37, issue.6, pp.1590-1596, 2014.

M. Bécard, A. Vambergue, C. Coulon, C. Fermont, F. Pirard et al., Diabète prégestationnel et grossesse, EMC - Obstétrique, vol.5, issue.3, pp.1-9, 2010.

E. Cosson, Diabètes et grossesse. EMC -Endocrinol-Nutr, vol.16, issue.3, pp.1-18, 2019.

P. Boulot, N. Chabbert-buffet, C. Ercole, M. Floriot, P. Fontaine et al., French Multicentric Survey of Outcome of Pregnancy in Women With Pregestational Diabetes, Diabetes Care, vol.26, issue.11, pp.2990-2993, 2003.

S. Hiéronimus, C. Cupelli, M. Durand-réville, A. Bongain, and P. Fénichel, Grossesse et diabète de type 2 : quel pronostic f?tal ?, Gynécologie Obstétrique & Fertilité, vol.32, issue.1, pp.23-27, 2004.

F. Bretelle and B. Blanc, Pour ou contre la césarienne de « convenance » ?Gynecol Obstet Fertil 2004 ; 32 : 347-351, Gynécologie Obstétrique & Fertilité, vol.32, issue.9, pp.835-835, 2004.

M. F. Jannot-lamotte, S. Hamzaoui, D. Raccah, and M. Gamerre, Diabète de type 2 et grossesse : pronostic maternel et foetal, Lett Gynécologue, pp.16-21, 2009.

J. M. Lawrence, S. E. Andrade, L. A. Avalos, S. J. Beaton, V. Y. Chiu et al., Prevalence, Trends, and Patterns of Use of Antidiabetic Medications Among Pregnant Women, 2001-2007, Obstetrics & Gynecology, vol.121, issue.1, pp.106-114, 2013.

C. A. Knox, J. A. Delaney, and A. G. Winterstein, Anti-diabetic drug utilization of pregnant diabetic women in us managed care, BMC Pregnancy and Childbirth, vol.14, issue.1, pp.1-8, 2014.

R. A. Charlton, K. Klungsøyr, A. J. Neville, S. Jordan, A. Pierini et al., Prescribing of Antidiabetic Medicines before, during and after Pregnancy: A Study in Seven European Regions, PLOS ONE, vol.11, issue.5, p.e0155737, 2016.

C. Gilbert, M. Valois, and G. Koren, Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis, Fertility and Sterility, vol.86, issue.3, pp.658-663, 2006.

M. Cassina, M. Donà, E. Di-gianantonio, P. Litta, and M. Clementi, First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis, Human Reproduction Update, vol.20, issue.5, pp.656-669, 2014.

P. Kitwitee, S. Limwattananon, C. Limwattananon, O. Waleekachonlert, T. Ratanachotpanich et al., Metformin for the treatment of gestational diabetes: An updated meta-analysis, Diabetes Research and Clinical Practice, vol.109, issue.3, pp.521-532, 2015.

S. Scherneck, N. Schlinke, E. Beck, K. Grupe, C. Weber-schoendorfer et al., Pregnancy outcome after first-trimester exposure to metformin: A prospective cohort study, Reproductive Toxicology, vol.81, pp.79-83, 2018.

M. E. Moretti, M. Rezvani, and G. Koren, Safety of Glyburide for Gestational Diabetes: A Meta-Analysis of Pregnancy Outcomes, Annals of Pharmacotherapy, vol.42, issue.4, pp.483-490, 2008.

J. Tieu, S. Coat, W. Hague, P. Middleton, and E. Shepherd, Oral anti-diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre-existing diabetes, Cochrane Database of Systematic Reviews, vol.10, p.7724, 2017.

J. D. Walker, NICE guidance on diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. NICE clinical guideline 63. London, March 2008, Diabetic Medicine, vol.25, issue.9, pp.1025-1027, 2008.

M. W. Reed, Scottish Intercollegiate Guidelines Network (SIGN) 84 ? National Clinical Guideline for the Management of Breast Cancer in Women1, Clinical Oncology, vol.19, issue.8, pp.588-590, 2007.

M. Yapa and D. Simmons, Screening for gestational diabetes mellitus in a multiethnic population in New Zealand, Diabetes Research and Clinical Practice, vol.48, issue.3, pp.217-223, 2000.

D. Sur,

J. L. Kitzmiller, J. M. Block, F. M. Brown, P. M. Catalano, D. L. Conway et al., Managing Preexisting Diabetes for Pregnancy: Summary of evidence and consensus recommendations for care, Diabetes Care, vol.31, issue.5, pp.1060-1079, 2008.

, ACOG Practice Bulletin No. 201, Obstetrics & Gynecology, vol.132, issue.6, pp.e228-e248, 2018.

H. Hili, Accreditation in Primary Health: RACGP Standards for General Practice, Health Information Management, vol.31, issue.2, pp.1-6, 2003.

L. Renesme, Herpès néonatal : épidémiologie, manifestations cliniques et prise en charge. Recommandations pour la pratique clinique du Collège national des gynécologues obstétriciens français (CNGOF), Gynécologie Obstétrique Fertilité & Sénologie, vol.45, issue.12, pp.691-704, 2017.

:. Paris and . Cngof;, GWT-RPC, 2010.

J. Buxeraud, Le Centre de référence sur les agents tératogènes, Actualités Pharmaceutiques, vol.59, issue.594, pp.31-32, 2020.

J. Buxeraud, Le Centre de référence sur les agents tératogènes, Actualités Pharmaceutiques, vol.59, issue.594, pp.31-32, 2020.

A. A. Mitchell, Systematic Identification of Drugs That Cause Birth Defects ? A New Opportunity, New England Journal of Medicine, vol.349, issue.26, pp.2556-2559, 2003.

A. Panchaud, D. Baud, T. Vial, N. Bernard, E. Amar et al., Pregnancy Outcome following Maternal Exposure to Metformin: Preliminary Results of a Collaborative ENTIS and Motherisk Study, Birt Defects Res A Clin Mol Teratol, vol.100, issue.7, p.521, 2014.

T. Beaudet, Une assurance maladie à 100 % : faut-il vraiment se passer des complémentaires santé ?, Les Tribunes de la santé, vol.N°65, issue.3, p.95, 2020.

, Graphique 6.10. Individus ayant communiqué des données personnelles sur l'internet, 2016

C. Billionnet, A. Weill, P. Ricordeau, F. Alla, D. F. Mitanchez et al., O61 Diabète pregestationnel (type 1 et 2) et grossesse : données de la population française 2011, Diabetes & Metabolism, vol.40, issue.1, p.A15, 2014.

C. Billionnet, A. Weill, P. Ricordeau, F. Alla, D. F. Mitanchez et al., O62 Diabète gestationnel et grossesse : données de la population française 2011, Diabetes & Metabolism, vol.40, issue.1, p.A15, 2014.

C. Piffaretti, V. Looten, S. Rey, J. Fresson, A. Fagot-campagna et al., Prises en charge de la grossesse au travers de la consommation de soins des femmes ayant accouché en France en 2015 : une étude observationnelle à l?aide du système national des données de santé (SNDS), Revue d'Épidémiologie et de Santé Publique, vol.66, issue.1, pp.S14-S15, 2018.

. Ansm, Annexe 2. Adresses d?associations de patients et de proches, Traitements psychologiques des troubles bipolaires, pp.243-244, 2009.

F. Raguideau, P. O. Blotière, J. Coste, M. Zureik, R. Dray-spira et al., Persistance d?un niveau élevé d?exposition à l?acide valproïque parmi les femmes enceintes : les résultats d?une étude observationnelle sur les données du Sniiram/PMSI, Revue d'Épidémiologie et de Santé Publique, vol.65, issue.1, p.S24, 2017.

R. Demailly, S. Escolano, C. Quantin, P. Tubert-bitter, and I. Ahmed, Prescription drug use during pregnancy in France: a study from the national health insurance permanent sample, Pharmacoepidemiology and Drug Safety, vol.26, issue.9, pp.1126-1134, 2017.

M. Luu, E. Benzenine, M. Doret, C. Michiels, C. Quantin et al., L?utilisation des antiTNF? pendant la grossesse augmente le risque de complications chez les femmes atteintes de maladies inflammatoires chroniques de l?intestin. Cohorte rétrospective sur le Système national d?information inter-régimes de l?assurance maladie (EVASION), Revue d'Épidémiologie et de Santé Publique, vol.66, issue.1, p.S21, 2018.

. Ansm, C. Ehrhardt, R. Dray-spira, M. Zureik, P. O. Blotiere et al., Exposition à l'acide valproïque et ses dérivés au cours de la grossesse en France de, une étude observationnelle sur les données du Sniiram, 2007.

C. Ponte, Principales dispositions de la loi de modernisation de notre système de santé, Soins Aides-Soignantes, vol.13, issue.71, pp.27-28, 2016.

J. Bezin, M. Duong, R. Lassalle, C. Droz, A. Pariente et al., The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology, Pharmacoepidemiology and Drug Safety, vol.26, issue.8, pp.954-962, 2017.

, Mise en ?uvre du Système de comptabilité nationale 2008, 2016.

D. Circulaire, relative au chaînage des séjours en établissements de santé dans le cadre du programme de médicalisation des systèmes d'information (PMSI) Bulletin officiel du ministère chargé de la santé, pp.197-210, 2001.

P. Tuppin, J. Rudant, P. Constantinou, C. Gastaldi-ménager, A. Rachas et al., Value of a national administrative database to guide public decisions: From the système national d?information interrégimes de l?Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France, Revue d'Épidémiologie et de Santé Publique, vol.65, issue.4, pp.S149-S167, 2017.

S. E. Inzucchi, R. M. Bergenstal, J. B. Buse, M. Diamant, E. Ferrannini et al., Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), Diabetologia, vol.55, issue.6, pp.1577-1596, 2012.

D. Kirpichnikov, S. I. Mcfarlane, and J. R. Sowers, Metformin: An Update, Annals of Internal Medicine, vol.137, issue.1, p.25, 2002.

L. P. Zhao, X. Y. Sheng, S. Zhou, T. Yang, L. Y. Ma et al., Metformin versus insulin for gestational diabetes mellitus: a meta-analysis, British Journal of Clinical Pharmacology, vol.80, issue.5, pp.1224-1234, 2015.

G. Li, S. Zhao, S. Cui, L. Li, Y. Xu et al., Effect comparison of metformin with insulin treatment for gestational diabetes: a meta-analysis based on RCTs, Archives of Gynecology and Obstetrics, vol.292, issue.1, pp.111-120, 2014.

E. Vanky, K. Zahlsen, O. Spigset, and S. M. Carlsen, Placental passage of metformin in women with polycystic ovary syndrome, Fertility and Sterility, vol.83, issue.5, pp.1575-1578, 2005.

A. Panchaud, V. Rousson, T. Vial, N. Bernard, D. Baud et al., Pregnancy outcomes in women on metformin for diabetes or other indications among those seeking teratology information services, British Journal of Clinical Pharmacology, vol.84, issue.3, pp.568-578, 2018.

P. O. Blotière, A. Weill, M. Dalichampt, C. Billionnet, M. Mezzarobba et al., Development of an algorithm to identify pregnancy episodes and related outcomes in health care claims databases: An application to antiepileptic drug use in 4.9 million pregnant women in France, Pharmacoepidemiology and Drug Safety, vol.27, issue.7, pp.763-770, 2018.

A. Bénard-laribière, E. Pambrun, A. Sutter-dallay, S. Gautier, C. Hurault-delarue et al., Patterns of antidepressant use during pregnancy: a nationwide population-based cohort study, British Journal of Clinical Pharmacology, vol.84, issue.8, pp.1764-1775, 2018.

S. Li, N. Ford, K. Meister, and J. Bodurtha, Increased risk of birth defects among children from multiple births, Birth Defects Research Part A: Clinical and Molecular Teratology, vol.67, issue.10, pp.879-885, 2003.

P. Mastroiacovo, E. E. Castilla, C. Arpino, B. Botting, G. Cocchi et al., Congenital malformations in twins: An international study, American Journal of Medical Genetics, vol.83, issue.2, pp.117-124, 1999.

A. Kinsner-ovaskainen, M. Lanzoni, M. Bubenheim, and S. Martin, A sustainable solution for the activities of the European Network for Surveillance of Congenital Anomalies: EUROCAT as part of the EU Platform on Rare Diseases Registration, European Journal of Public Health, vol.28, issue.suppl_4, 2018.

L. K. Callaway, A. M. Chang, H. D. Mcintyre, and J. B. Prins, The prevalence and impact of overweight and obesity in an Australian obstetric population, Medical Journal of Australia, vol.184, issue.2, pp.56-59, 2006.

M. Hoeltzenbein, T. Tissen-diabaté, A. Fietz, S. Zinke, A. Kayser et al., Increased rate of birth defects after first trimester use of angiotensin converting enzyme inhibitors ? Treatment or hypertension related? An observational cohort study, Pregnancy Hypertension, vol.13, pp.65-71, 2018.

M. Van-gelder, C. M. Van-bennekom, C. Louik, M. M. Werler, N. Roeleveld et al., Maternal hypertensive disorders, antihypertensive medication use, and the risk of birth defects: a case-control study, BJOG: An International Journal of Obstetrics & Gynaecology, vol.122, issue.7, pp.1002-1009, 2014.

J. E. Given, M. Loane, E. Garne, M. Addor, M. Bakker et al., Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study, BMJ, vol.361, p.k2477, 2018.

E. Garne, M. Loane, H. Dolk, I. Barisic, M. Addor et al., Spectrum of congenital anomalies in pregnancies with pregestational diabetes, Birth Defects Research Part A: Clinical and Molecular Teratology, vol.94, issue.3, pp.134-140, 2012.

S. C. Tinker, S. M. Gilboa, C. A. Moore, D. K. Waller, R. M. Simeone et al., Specific birth defects in pregnancies of women with diabetes: National Birth Defects Prevention Study, 1997?2011, American Journal of Obstetrics and Gynecology, vol.222, issue.2, pp.176.e1-176.e11, 2020.

S. Dukhovny, C. M. Van-bennekom, D. R. Gagnon, S. Hernandez-diaz, S. E. Parker et al., Metformin in the first trimester and risks for specific birth defects in the National Birth Defects Prevention Study, Birth Defects Research, vol.110, issue.7, pp.579-586, 2018.

A. Correa, S. M. Gilboa, L. M. Besser, L. D. Botto, C. A. Moore et al., Metformin in women with type 2 diabetes in pregnancy (MiTy): a multi-center randomized controlled trial, e9. 67. on behalf of the MiTy Collaborative Group, vol.199, p.173, 2008.

S. Fuentes, E. Cosson, L. Mandereau-bruno, A. Fagot-campagna, P. Bernillon et al., Identifying diabetes cases in health administrative databases: a validation study based on a large French cohort, International Journal of Public Health, vol.64, issue.3, pp.441-450, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02623934

P. Tuppin, L. De-roquefeuil, A. Weill, P. Ricordeau, and Y. Merlière, French national health insurance information system and the permanent beneficiaries sample, Revue d'Épidémiologie et de Santé Publique, vol.58, issue.4, pp.286-290, 2010.

E. A. Reece, Diabetes-Induced Birth Defects: What Do We Know? What Can We Do?, Current Diabetes Reports, vol.12, issue.1, pp.24-32, 2011.

M. J. Lucas, K. J. Leveno, M. L. Williams, P. Raskin, and P. J. Whalley, Early pregnancy glycosylated hemoglobin, severity of diabetes, and fetal malformations, International Journal of Gynecology & Obstetrics, vol.31, issue.3, pp.305-305, 1990.

A. Guerin, R. Nisenbaum, and J. G. Ray, Use of Maternal GHb Concentration to Estimate the Risk of Congenital Anomalies in the Offspring of Women with Prepregnancy Diabetes, Diabetes Care, vol.30, issue.7, pp.1920-1925, 2007.

J. Benevent, M. Araujo, C. Hurault-delarue, J. Montastruc, A. Sommet et al., Pharmacoepidemiology in pregnancy, Therapies, vol.74, issue.2, pp.289-300, 2019.

, ANNEXES Annexe 1. Autorisations réglementaires C02AB02, pp.10-13

. Societefrancaisedepediatrieco, Acide folique et grossesseFolic acid and pregnancy, Archives de Pédiatrie, vol.2, issue.2, 1995.

:. Abréviations and . Atc, Abréviations, Pharmacie Clinique et Thérapeutique, pp.xxiii-xxxi, 2018.

C. Maillard, Les médecins ont-ils la possibilité de prescrire sous dénomination commune internationale (DCI) ?, Médecine & Droit, vol.1997, issue.26, p.6, 1997.